(Q37704397)

22 August 2017

1 reference

title

Treatment of Acinetobacter infections (English)

1 reference

22 August 2017

2

Matthew E Falagas

1 reference

22 August 2017

Argyris Michalopoulos

series ordinal

1

1 reference

PubMed ID

20210684

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Expert Opinion on Pharmacotherapy

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

5

1 reference

22 August 2017

779-788

1 reference

Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Acinetobacter baumannii: emergence of a successful pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

21 January 2018

Acinetobacter infection

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Two consecutive outbreaks of Acinetobacter baumanii 1-a in a burn Intensive Care Unit for adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Completely resistant Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Tigecycline in vitro activity against commonly encountered multidrug-resistant gram-negative pathogens in a Middle Eastern country

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Acinetobacter infections: a growing threat for critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Ampicillin/sulbactam: current status in severe bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Drug treatment for multidrug-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Multidrug-resistant Gram-negative infections: what are the treatment options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Tigecycline for the treatment of Acinetobacter infections: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Nosocomial Acinetobacter pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Treatment of multidrug resistant Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Colistin and polymyxin B in critical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Treatment options for multidrug-resistant Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Overview of nosocomial infections caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Bronchial constriction and inhaled colistin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Management of meningitis due to antibiotic-resistant Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Role of old antibiotics in multidrug resistant bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Management of severe abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003596350

10.1517/14656561003596350

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20210684